# Aurinia Pharmaceuticals Inc.: Form D filing

Aurinia Pharmaceuticals Inc., a biotechnology company in Victoria, British Columbia, Canada, filed a Form D with the SEC in 2014. The latest, on February 28, 2014, reports $52 million sold of a $52 million offering to 22 investors.

Find out what Aurinia Pharmaceuticals Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Aurinia%20Pharmaceuticals%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Aurinia%20Pharmaceuticals%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Faurinia-pharmaceuticals-inc-1600620)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Aurinia%20Pharmaceuticals%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Aurinia%20Pharmaceuticals%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Faurinia-pharmaceuticals-inc-1600620)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: #1203-4464 MARKHAM STREET, Victoria, British Columbia, Canada, V8Z 7
- Phone: (250) 708-4272
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Alberta, Canada
- Year incorporated: 2009
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1600620

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Feb 28, 2014 | New notice | $52,000,000 | $52,000,000 | $0 | 22 | Feb 14, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1600620/000160062014000001/0001600620-14-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Kurt von M. Emster | Director |  |
| Benjamin M. Rovinski | Director |  |
| Chris M. Kim | Director |  |
| Donald M. Wyatt | Director |  |
| Stephen W. Zaruby | Executive Officer, Director |  |
| Michael M. Martin | Executive Officer, Director |  |
| Dennis M. Bourgeault | Executive Officer |  |
| Daniel M. Park | Director |  |
| Richard M. Glickman | Executive Officer, Director |  |
| Peter M. Wijngaard | Director |  |

[Every Form D from the week of Feb 24, 2014](https://specstream.ai/data/form-d/week/2014-02-24) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Aurinia Pharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).